Search results
PRESS DIGEST- Financial Times - May 15
Reuters via Yahoo Finance· 12 hours agoBritain's attempt to continue collaborating in the world's largest nuclear fusion experiment has been rebuffed by the EU, which wants Britain to rejoin its civil atomic programme as part of ...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
Motley Fool via Yahoo Finance· 3 days agoStill, that's nothing new for companies in the pharmaceutical business, and its strong pipeline...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 6 days agoThe oncology market is known for its strong pricing power, with cancer drugs typically carrying high price tags and significant margins. While Pfizer's...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 6 days ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food ...
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Dropsuite Limited's (ASX:DSE)...
Simply Wall St. via Yahoo Finance· 20 hours agoWe've identified 1 warning sign for Dropsuite that investors should be aware of in a dynamic...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 7 days agoZepbound, its drug to treat chronic obesity, was approved by the FDA in November 2023. Revenue for...
A new anime adaptation of a beloved manga feels like a classic Marvel comic in the best way, and it...
Games Radar· 6 days agoConsidering the recent explosion of international interest in kaiju cinema, from the Academy...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 5 days agoWeaknesses underscore the challenges in revenue fluctuations and patent expirations. Opportunities emphasize potential growth in emerging markets and R&D...
Retail’s Timid Transformation Trap
Forbes· 12 hours agoBed, Bath & Beyond, Blockbuster, Borders, Circuit City, RadioShack, and, most notably, Sears, once the most valuable retailer on the planet—and where I...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 2 days agoSimilar to CRSwNP, the COPD application was accepted under priority review. Dupixent saw sales of...
